Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy

Shahrizaila, N.; Noto, Y.; Simon, N. G.; Huynh, W.; Shibuya, K.; Matamala, J. M.; Dharmadasa, T.; Devenney, E.; Kennerson, M. L.; Nicholson, G. A.; Kiernan, M. C.


Objective: The utility of quantitative muscle ultrasound as a marker of disease severity in Charcot-Marie-Tooth (CMT) disease subtypes was investigated. Methods: Muscle ultrasound was prospectively performed on 252 individual muscles from 21 CMT patients (9 CMT1A, 8 CMTX1, 4 CMT2A) and compared to 120 muscles from 10 age and gender-matched controls. Muscle ultrasound recorded echogenicity and thickness in representative muscles including first dorsal interosseus (FDI) and tibialis anterior (TA). Results: Muscle volume of FDI and thickness of TA correlated with MRC strength. Muscle echogenicity was significantly increased in FDI (65.05 vs 47.09; p 0.0001) and TA (89.45 vs 66.30; p 0.0001) of CMT patients. In TA, there was significantly higher muscle thickness (23 vs 18 vs 16 mm; p 0.0001) and lower muscle echogenicity (80 vs 95 vs 108; p 0.0001) in CMT1A compared to CMTX1 and CMT2A. This corresponded to disease severity based on muscle strength (MRC grading CMT1A vs CMTX1 vs CMT2A: 59 vs 48 vs 44; p = 0.002). Conclusion: In CMT, quantitative muscle ultrasound of FDI and TA is a useful marker of disease severity. Significance: The current findings suggest that quantitative muscle ultrasound has potential as a surrogate marker of disease progression in future interventional trials in CMT. (C) 2016 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Más información

Título según WOS: ID WOS:000396377300025 Not found in local WOS DB
Volumen: 128
Número: 1
Fecha de publicación: 2017
Página de inicio: 227
Página final: 232


Notas: ISI